The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The FDA Is Unbanning Peptides! (BPC 157, TB 500) #peptides #breakingnews